Eli Lilly plans to build a $6.5 billion factory in Houston, with construction expected to be completed by 2030.
GlobalData on MSN
Eli Lilly to build $6.5bn orforglipron production site in Texas
Eli Lilly has revealed it is to build an active pharmaceutical product (API) facility in Texas, US, a week after revealing ...
The pharmaceutical giant’s expansion into Texas will create 615 full-time jobs and receive $5.5 million in state funding.
Eli Lilly and Company plans to invest $6.5 billion to build a manufacturing facility at Generation Park in Houston, Texas.
Pharma giant Eli Lilly confirmed plans for the plant in Houston where an oral GLP-1 weight loss drug could be made, creating ...
Eli Lilly's massive investment in Houston is even larger than it initially proposed just four months ago when it applied for ...
Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...
Eli Lilly and Co. (NYSE: LLY) confirmed Sept. 23 that the Bayou City will be part of its domestic manufacturing push. David ...
Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...
Eli Lilly (LLY) stock is in focus as the company plans to invest $6.5B to build a new Houston plant for small molecule drugs, ...
The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results